Eli Lilly and Co
Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start
Mike Doustdar, CEO of Novo Nordisk, speaks in the Oval Office during an event about weight loss drugs at the White House, Nov. 6, 2025. Andrew Caballero-Reynolds | Afp | Getty Images Novo Nordisk entered 2026 with the momentum of a historic year in more ways than one — but recent weeks have delivered more […]
Read More
Novo Nordisk CEO sees 15 million-patient opportunity in Medicare coverage for obesity drugs
Novo Nordisk CEO Mike Doustdar. CNBC Novo Nordisk CEO Mike Doustdar on Wednesday said the company is aiming to capture around 15 million new patients, at least initially, when Medicare starts covering obesity treatments for the first time later this year. Around 67 million Americans are covered by Medicare, but “when you take a look […]
Read More
FDA says Novo Nordisk’s TV ad for obesity pill includes ‘false or misleading’ claims
Still life of the new Wegovy semaglutide tablets on a white background. Its a prescription medicine used with a reduced calorie diet and .and physical activity. Michael Siluk | Universal Images Group | Getty Images The Food and Drug Administration said Novo Nordisk‘s TV advertisement for its newly launched Wegovy pill for obesity included “false […]
Read More
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. Tom Little | Reuters Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in […]
Read More
Dow 50,000, Super Bowl 60, Meta’s big week in court and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Monday. Congratulations to the Seattle Seahawks, who stifled the New England Patriots in a 29-13 Super Bowl win last night. Congratulations also to Lady Gaga fans, who got a surprise performance from the singer during Bad Bunny’s halftime show. Stock futures […]
Read More
Here are 3 major moments that drove the stock market last week
A massive market snapback on Friday couldn’t erase all of the week’s damage. After several days of selling, the tech sector roared back, with the Nasdaq gaining over 2% on Friday. Chipmakers Nvidia and Broadcom led the way, with gains of 7.8% and 7.2%, respectively. The broad-based S & P 500 rose nearly 2% in […]
Read More
Stocks making the biggest moves midday: Amazon, Centene, Roblox and more
Check out the companies making headlines in midday trading. Centene — Shares of the health insurance provider slid 5%. Guidance for full-year revenue came in at $186.5 billion to $190.5 billion, missing the FactSet consensus call for $194.1 billion. The outlook for premium and service revenue for the year was also shy of Wall Street […]
Read More
Stocks making the biggest moves premarket: Amazon, Reddit, Strategy, Molina, Strategy, Eli Lilly & more
Check out the companies making headlines before the bell. Amazon — Shares tumbled 7% after the ecommerce giant reported $1.95 in earnings per share in the fourth quarter, narrowly missing the consensus forecast of $1.97 per share from analysts polled by LSEG. Amazon also said to expect $200 billion in capital expenditures for 2026. Molina […]
Read More
Hims & Hers falls 8% after Novo’s legal threat. Here’s the latest
Rafael Henrique | SOPA Images | AP The stock of Hims & Hers dropped in premarket trading early Friday after a legal threat from Novo Nordisk. The online teleheath company announced on Thursday plans to launch a cheaper, copycat version of Novo’s weight loss pill, prompting Novo to take legal action. Hims stock spiked as […]
Read More
The White House is launching direct-to-consumer drug site Trump Rx. Here’s what to know
U.S. President Donald Trump makes an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday is slated to announce the launch of TrumpRx – a direct-to-consumer website that is key to his administration’s efforts to lower prescription drug costs […]
Read More